DKK1 Impairs The Tumor Response to Αpd‐1 Immunotherapy by Inactivating CD8+ T Cells And Recruiting Mdsc Cells in Hnsc
Advanced Therapeutics(2023)
摘要
Abstract Background: The utilization of immune checkpoint inhibitors (ICIs) has received authorization for the treatment of head and neck squamous cell carcinoma (HNSC) and various other tumor types. However, a large proportion of HNSC patients exhibit unresponsiveness to ICIs. Dickkopf‐1 (DKK1), a secreted protein with pivotal functions in Wnt signaling pathways, has been increasingly recognized for its role in modulating anti‐tumor immunity. This article is protected by copyright. All rights reserved
更多查看译文
关键词
dkk1 impairs,tumor response,recruiting mdsc cells
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要